ImmunityBio (IBRX) Depreciation and Depletion (2016 - 2026)
ImmunityBio (IBRX) posted quarterly Depreciation and Depletion of $3.3 million for Q1 2026, little changed year-over-year from $3.3 million in Q1 2025, and little changed quarter-over-quarter from $3.3 million in Q4 2025.
ImmunityBio (IBRX) Depreciation and Depletion (2016 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Depreciation and Depletion for 11 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $13.4 million (down 8.84% YoY), while the FY2025 annual figure was $13.4 million, down 13.55% from the prior year.
- Depreciation and Depletion held at $3.3 million in Q1 2026 per IBRX's latest filing, from $3.3 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $4.6 million in Q4 2022 and bottomed at $3.3 million in Q1 2025.
- Historically, Depreciation and Depletion has averaged $3.8 million across 5 years, with a median of $3.9 million in 2022.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion grew 27.78% — and 2025, when it decreased 17.5%.
- ImmunityBio's Depreciation and Depletion stood at $4.6 million in 2022, then retreated by 10.87% to $4.1 million in 2023, then dropped by 12.2% to $3.6 million in 2024, then fell by 8.33% to $3.3 million in 2025, then changed by 0.0% to $3.3 million in 2026.
- Business Quant data shows IBRX's Depreciation and Depletion at $3.3 million in Q1 2026, $3.3 million in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.30 Mn |
| Mar 31, 2026 | 3.30 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |